Carpal Tunnel Syndrome (CTS)
Conditions
Keywords
carpal tunnel syndrome, Kinesiotaping, Sham taping
Brief summary
Objective: Kinesiotaping (KT) is a relatively new technique, which reduces the pressure on the median nerve by extending the transverse carpal ligament. The aim of this study was to evaluate the effectiveness of KT on Carpal tunnel syndrome (CTS) in a randomized, placebo-controlled manner. Methods: Patients were randomly divided into three groups: Group 1 (KT plus tendon and nerve gliding exercises), Group 2 (sham-taping plus exercises) and Group 3 (exercises alone, control group). KT was applied 3 times with 5-day intervals throughout the study, with neural technique for median and ulnar nerves and area correction technique for carpal tunnel releasing. In the placebo group kinesiotapes were applied without stretching and proper position. Hand grip strength, VAS, Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), and Short Form-12 (SF-12) were measured as outcome parameters at the first visit, 3rd and 6th week.
Interventions
DEVICEKinesiotape
Kinesiotape, when applied with a specific method and tension, significantly reduces the pressure on the median nerve by extending the transverse carpal ligament. It regulates edema under the skin and improves lymphatic and blood circulation. It reduces muscle spasms, eases the movement of tendons and fascia, and reduces pain through neurological suppression
OTHERExercise
Tendon and nerve gliding exercise
DEVICEsham taping
In the sham taping group, kinesiotape was applied with two I bands without stretching and without having the proper position. This group was considered as the placebo group.
Sponsors
Karadeniz Technical University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* clicical diagnosis of mild and moderate CTS * having the CTS symptoms for at least 6 weeks
Exclusion criteria
* electrophysiological diagnosis of severe CTS, * thenar atrophy, * local corticosteroid injection or KT application or physical therapy treatment for CTS within the last 3 months, * patients with secondary metabolic causes for CTS (such as diabetes mellitus, pregnancy, rheumatoid arthritis, sarcoidosis, thyroid disease), * patients with other conditions that may cause neck and arm pain (cervical disc hernia, arthritis, epicondylitis, rotator cuff syndrome), * a history of fracture in the wrist, * previous CTS surgery.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain level | From enrollment to the end of treatment at 3 weeks | pain level was assessed using visual analog scale.The minimum and maximum values were 0 and 10, and higher scores mean a better outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) | From enrollment to the end of treatment at 6 weeks | The BCTQ is a disease specific questionnaire to evaluate the symptom severity and functional capacity. High scores indicate increased symtom severity and low functional capacity |
Countries
Turkey (Türkiye)
Outcome results
None listed